Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew
IDET™
INTRADISCAL ELECTROTHERMAL™ Therapy
About Discogenic Lower Back Pain
Lower back pain—acute and chronic—is second only to upper respiratory infection as the reason for primary care physician visits in the United States, and it is the costliest musculoskeletal complaint.
- It is estimated that from 80% to 90% of people in the United States will experience at least one episode of lower back pain in their lifetime.
- Most cases of acute back pain are self-limiting, and when treated in accordance with evidence-based guidelines, more than 70% of acute patients become pain free.
- Between 70% and 90% of those who have one episode will have at least one recurrence, and of those, about 33% have lower back pain more than half the days of the year.
- The lifetime U.S. prevalence of chronic lower back pain (>3 months duration) is 10%-20%.
- Approximately 5% of patients with chronic lower back pain have severe, disabling pain that incurs significant expense and can take a serious psychosocial toll on patients and their families.
Significant Personal & Societal costs
An estimated 175 million workdays are lost to low back pain each year in the United States—a $20 billion loss of productivity.
- Lower back pain represents 15% of workers’ compensation claims and 25% of all claim costs.
- The annual direct and indirect costs of lower back pain in the United States total more than $100 billion.
For more specific information about discogenic lower back pain, please review the following resources: